
To combat the national shortage of diagnostic tests for the new coronavirus, SARS-CoV-2, the Federal Drug Administration (FDA) gave authorization to UW Medicine to test patient specimens provided by physicians and health care providers, according to two UW Me⦠[+7383 chars]Source